Grants are designed to foster and strengthen research capacity and innovation and improve the quality of care for addiction and mental health patients in Alberta.
We are seeking a research team to conduct a rapid systematic review on the safety and effectiveness of opioid agonist therapy (OAT) medications including methadone, oral buprenorphine/naloxone, injectable depot buprenorphine, and slow-release oral morphine. $25,000 is available to conduct this review and applications will be accepted until January 15, 2024. Please see the program guide and application form in the link below for more details.
We will provide up to five $1,000 grants to support researchers incorporating meaningful patient engagement in research projects in Addiction and Mental Health. Submissions for projects on any topic are welcome, but priority will be given to those that align with our key priority areas of Child and Youth Mental Health, Indigenous Mental Health and Addiction, Care for Underserved Populations, Improving Access to Services and Continuity of Care, and Virtual Health Services. Applications will be accepted on a rolling basis until March 31, 2024. Please see the program guide and application form in the link below for more details.
